Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure

Journal of Perinatology

Volumn 28, Issue 6, 2008, Pages 405-411

  Weitkamp, J H ^a   Ozdas, A ^b   LaFleur, B ^b   Potts, A L ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEPHALOSPORIN; FLUCONAZOLE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ARTICLE; BIRTH WEIGHT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; FUNGEMIA; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GESTATIONAL AGE; HEMATOLOGIC DISEASE; HIGH RISK INFANT; HUMAN; INFANT; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALASSEZIA PACHYDERMATIS; PATIENT COMPLIANCE; PREMATURITY; PROPHYLAXIS; RETROSPECTIVE STUDY; SYSTEMIC MYCOSIS;

ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MEDICAL ORDER ENTRY SYSTEMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44649129466     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211914     Document Type: Article

References (27)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291.
2. Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E et al. Risk factors for candidemia in critically ill infants: A matched case-control study. J Pediatrics 2005; 147: 156-161.
3. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000; 19: 319-324.
4. Benjamin Jr DK, Ross K, McKinney Jr RE, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000; 106: 712-718.
5. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff M. Fungal colonization in the very low birth weight infant. Pediatrics 1986; 78: 225-232.
6. Saiman L, Ludington F, Dawson JD, Patterson JE, Rangel-Frausto S, Wiblin RT et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20: 1119-1124.
7. Kaufman D, Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M et al Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345: 1660-1666.
8. Smith PB, Morgan J, Benjamin JD, Fridkin SK, Sanza LT, Harrison LH et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 2007; 26: 197-200.
9. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of < 1000 grams birth weight. J Pediatr 2005; 147: 172-179.
10. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr 2005; 147: 166-171.
11. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 2005; 147: 162-165.
12. Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA et al Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: A single-center, 6-year, retrospective cohort study. Pediatrics 2006; 117: E22-e32.
13. McCrossan BA, McHenry E, O'Neil F, Ong G, Sweet DG. Selective fluconazole prophylaxis in high risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed 2007; 92: F454-F458.
14. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L et al Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 2006; 117: 1243-1252.
15. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007; 356: 2483-2495.
16. Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol 2006; 26: 550-555.
17. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2004; (1): CD003850.
18. Martinez Sesmero JM, Farfan Sedano FJ, Molina Garcia T, Brussi MM, Sanchez-Rubio Ferrandez J, Diez Fernandez R et al. Fungal chemoprophylaxis with fluconazole in preterm infants. Pharm World Sci 2005; 27: 475-477.
19. Alangaden G, Chandrasekar PH, Bailey E, Khaliq Y. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team. Bone Marrow Transplant 1994; 14 919-924.
20. Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst Rev 2004; (3): CD004291.
21. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: A survey of perinatal physician practices. Pediatrics 2006; 118: E1019-e1026.
22. Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: Management choices, infection control, and fluconazole prophylaxis. J Pediatr 2005; 147: 135-141.
23. Fanaroff AA. Fluconazole for the prevention of fungal infections: Get ready, get set, caution. Pediatrics 2006; 117: 214-215.
24. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 2006; 117: 1680-1687.
25. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M et al. National epidemiology of mycoses survey NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253-258.
26. Lin MY, Carmeli Y, Zumsteg J, Flores EL, Tolentino J, Sreeramoju P et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: A case-case-control study. Antimicrob Agents Chemother 2005; 49 4555-4560.
27. Novelli V, Holzel H. Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother 1999; 43: 1955-1960.